ArticleFrontiers in oncology2023

Blood immune cells as potential biomarkers predicting relapse-free survival of stage III/IV resected melanoma patients treated with peptide-based vaccination and interferon-alpha.

Federica Moschella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.